Assertio Holdings Inc
ASRT0.714USD
+0.001+0.21%
交易中 （美東）報價延遲15分鐘
68.38M總市值
虧損本益比TTM
關於 Assertio Holdings Inc 公司
Assertio Holdings, Inc. 是一家爲患者提供差異化產品的商業製藥公司。該公司通過收購或授權已獲批准的產品建立了自己的商業組合。其全面的商業能力包括通過銷售團隊和非個人推廣模式進行營銷、通過付款人簽約進入市場以及貿易和分銷。該公司的主要營銷產品包括 ROLVEDONTM（eflapegrastim-xnst）皮下注射劑、INDOCIN（吲哚美辛）栓劑、INDOCIN（吲哚美辛）口服混懸液、Sympazan（氯巴佔）口服膜、Otrexup（甲氨蝶呤）皮下注射劑、SPRIX（酮咯酸氨丁三醇）鼻噴霧劑、CAMBIA（雙氯芬酸鉀口服溶液）和 Zipsor（雙氯芬酸鉀）液體膠囊。 INDOCIN（吲哚美辛）栓劑和 INDOCIN（吲哚美辛）口服混懸液產品是非甾體抗炎藥 (NSAID)。
公司簡介
公司代碼ASRT
公司名稱Assertio Holdings Inc
上市日期Feb 12, 1997
CEOMr. Brendan P. O'Grady
員工數量58
證券類型Ordinary Share
年結日Feb 12
公司地址100 S. Saunders Road
城市LAKE FOREST
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編60045
電話12244197106
網址https://www.assertiotx.com/
公司代碼ASRT
上市日期Feb 12, 1997
CEOMr. Brendan P. O'Grady
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Ajay Patel
Mr. Ajay Patel
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
196.85K
+12.05%
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
Executive Vice President, Chief Transformation Officer
Executive Vice President, Chief Transformation Officer
167.52K
+14.47%
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
156.13K
+17.33%
Mr. Brendan P. O'Grady
Mr. Brendan P. O'Grady
Chief Executive Officer, Director
Chief Executive Officer, Director
128.96K
+1001.61%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
107.50K
+100.00%
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
97.28K
+123.48%
Mr. Mark L Reisenauer
Mr. Mark L Reisenauer
Independent Director
Independent Director
53.75K
--
Ms. Heather L. Mason
Ms. Heather L. Mason
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Sigurd C. (Sig) Kirk
Mr. Sigurd C. (Sig) Kirk
Independent Director
Independent Director
--
--
Mr. Sravan K. Emany
Mr. Sravan K. Emany
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Ajay Patel
Mr. Ajay Patel
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
196.85K
+12.05%
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
Executive Vice President, Chief Transformation Officer
Executive Vice President, Chief Transformation Officer
167.52K
+14.47%
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
156.13K
+17.33%
Mr. Brendan P. O'Grady
Mr. Brendan P. O'Grady
Chief Executive Officer, Director
Chief Executive Officer, Director
128.96K
+1001.61%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
107.50K
+100.00%
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
97.28K
+123.48%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
ROLVEDON
13.12M
49.54%
INDOCIN products
5.54M
20.93%
other
3.56M
13.44%
Sympazan
2.18M
8.23%
SPRIX Nasal Spray
1.59M
6.00%
Royalties and milestone revenue
494.00K
1.86%
地區USD
名稱
營收
佔比
United States
26.49M
100.00%
業務
地區
業務USD
名稱
營收
佔比
ROLVEDON
13.12M
49.54%
INDOCIN products
5.54M
20.93%
other
3.56M
13.44%
Sympazan
2.18M
8.23%
SPRIX Nasal Spray
1.59M
6.00%
Royalties and milestone revenue
494.00K
1.86%
股東統計
更新時間: 5月16日 週五
更新時間: 5月16日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Nantahala Capital Management, LLC
8.81%
The Vanguard Group, Inc.
4.58%
Renaissance Technologies LLC
2.82%
BlackRock Institutional Trust Company, N.A.
1.45%
Two Sigma Investments, LP
1.28%
Other
81.06%
持股股東
持股股東
佔比
Nantahala Capital Management, LLC
8.81%
The Vanguard Group, Inc.
4.58%
Renaissance Technologies LLC
2.82%
BlackRock Institutional Trust Company, N.A.
1.45%
Two Sigma Investments, LP
1.28%
Other
81.06%
股東類型
持股股東
佔比
Hedge Fund
13.93%
Investment Advisor
9.29%
Investment Advisor/Hedge Fund
3.63%
Individual Investor
2.63%
Research Firm
0.15%
Other
70.37%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
311
28.39M
29.65%
-30.82M
2025Q1
337
28.16M
29.40%
-32.55M
2024Q4
339
31.00M
32.47%
-30.41M
2024Q3
330
33.06M
34.86%
-33.72M
2024Q2
326
40.98M
43.17%
-33.17M
2024Q1
316
48.96M
52.78%
-20.37M
2023Q4
308
49.49M
53.68%
-10.26M
2023Q3
295
49.25M
53.86%
+8.83M
2023Q2
258
36.71M
65.25%
+1.46M
2023Q1
203
27.95M
50.57%
+2.57M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Nantahala Capital Management, LLC
8.44M
8.81%
+291.43K
+3.58%
Mar 31, 2025
The Vanguard Group, Inc.
4.38M
4.58%
--
--
Mar 31, 2025
Renaissance Technologies LLC
2.70M
2.82%
-289.05K
-9.66%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.39M
1.45%
-13.17K
-0.94%
Mar 31, 2025
Two Sigma Investments, LP
1.23M
1.28%
-401.09K
-24.66%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.11M
1.16%
+11.78K
+1.08%
Mar 31, 2025
Millennium Management LLC
784.58K
0.82%
-316.70K
-28.76%
Mar 31, 2025
Polen Capital Management, LLC
424.06K
0.44%
-227.56K
-34.92%
Nov 30, 2024
AQR Capital Management, LLC
636.77K
0.66%
-265.80K
-29.45%
Mar 31, 2025
Peisert (Daniel A)
607.46K
0.63%
--
--
Mar 13, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Franklin US Small Cap Multifactor Index ETF
0%
ALPS Barron's 400 ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
Avantis Responsible US Equity ETF
0%
Global X Russell 2000 ETF
0%
Royce Quant Small-Cap Quality Value ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
查看更多
Invesco RAFI US 1500 Small-Mid ETF
佔比0.01%
Franklin US Small Cap Multifactor Index ETF
佔比0%
ALPS Barron's 400 ETF
佔比0%
iShares Russell 2000 Value ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
Avantis Responsible US Equity ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
Royce Quant Small-Cap Quality Value ETF
佔比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0%
Avantis US Small Cap Equity ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
May 17, 2021
Merger
4<1
May 17, 2021
Merger
4<1
May 17, 2021
Merger
4<1
May 17, 2021
Merger
4<1
公告日期
類型
比率
May 17, 2021
Merger
4<1
May 17, 2021
Merger
4<1
May 17, 2021
Merger
4<1
May 17, 2021
Merger
4<1
